|
|
| Line 3: |
Line 3: |
| | <StructureSection load='4wzf' size='340' side='right'caption='[[4wzf]], [[Resolution|resolution]] 1.70Å' scene=''> | | <StructureSection load='4wzf' size='340' side='right'caption='[[4wzf]], [[Resolution|resolution]] 1.70Å' scene=''> |
| | == Structural highlights == | | == Structural highlights == |
| - | <table><tr><td colspan='2'>[[4wzf]] is a 2 chain structure with sequence from [http://en.wikipedia.org/wiki/Myctu Myctu]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4WZF OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4WZF FirstGlance]. <br> | + | <table><tr><td colspan='2'>[[4wzf]] is a 2 chain structure with sequence from [https://en.wikipedia.org/wiki/Mycobacterium_tuberculosis_H37Rv Mycobacterium tuberculosis H37Rv]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4WZF OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=4WZF FirstGlance]. <br> |
| - | </td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=CA:CALCIUM+ION'>CA</scene>, <scene name='pdbligand=EDO:1,2-ETHANEDIOL'>EDO</scene></td></tr> | + | </td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=CA:CALCIUM+ION'>CA</scene>, <scene name='pdbligand=EDO:1,2-ETHANEDIOL'>EDO</scene></td></tr> |
| - | <tr id='gene'><td class="sblockLbl"><b>[[Gene|Gene:]]</b></td><td class="sblockDat">Rv0315, RVBD_0315, LH57_01715, P425_00327 ([http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Info&srchmode=5&id=83332 MYCTU])</td></tr>
| + | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=4wzf FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4wzf OCA], [https://pdbe.org/4wzf PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=4wzf RCSB], [https://www.ebi.ac.uk/pdbsum/4wzf PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=4wzf ProSAT]</span></td></tr> |
| - | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4wzf FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4wzf OCA], [http://pdbe.org/4wzf PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=4wzf RCSB], [http://www.ebi.ac.uk/pdbsum/4wzf PDBsum], [http://prosat.h-its.org/prosat/prosatexe?pdbcode=4wzf ProSAT]</span></td></tr> | + | |
| | </table> | | </table> |
| | + | == Function == |
| | + | [https://www.uniprot.org/uniprot/O07242_MYCTU O07242_MYCTU] |
| | <div style="background-color:#fffaf0;"> | | <div style="background-color:#fffaf0;"> |
| | == Publication Abstract from PubMed == | | == Publication Abstract from PubMed == |
| Line 19: |
Line 20: |
| | | | |
| | ==See Also== | | ==See Also== |
| - | *[[Glucanase|Glucanase]] | + | *[[Glucanase 3D structures|Glucanase 3D structures]] |
| | == References == | | == References == |
| | <references/> | | <references/> |
| Line 25: |
Line 26: |
| | </StructureSection> | | </StructureSection> |
| | [[Category: Large Structures]] | | [[Category: Large Structures]] |
| - | [[Category: Myctu]] | + | [[Category: Mycobacterium tuberculosis H37Rv]] |
| - | [[Category: Dong, W Y]] | + | [[Category: Dong WY]] |
| - | [[Category: Fu, Z F]] | + | [[Category: Fu ZF]] |
| - | [[Category: Peng, G Q]] | + | [[Category: Peng GQ]] |
| - | [[Category: 3-glucanase]]
| + | |
| - | [[Category: Beta-1]]
| + | |
| - | [[Category: Dc maturation]]
| + | |
| - | [[Category: Gh16 laminarinase]]
| + | |
| - | [[Category: Hydrolase activator]]
| + | |
| - | [[Category: Mycobacterium tuberculosis]]
| + | |
| - | [[Category: Rv0315]]
| + | |
| Structural highlights
Function
O07242_MYCTU
Publication Abstract from PubMed
Mycobacterium tuberculosis (Mtb) remains a leading cause of morbidity and mortality worldwide, as two billion people are latently infected with Mtb. To address Mtb drug resistance and the limitations of current vaccines, the characteristics of candidate Mtb vaccines need to be explored. Here, we report the three-dimensional structure of Rv0315 at 1.70 A resolution, a novel immunostimulatory antigen of Mtb, and demonstrate that Rv0315 is an inactive beta-1,3-glucanase of the glycoside hydrolase 16 (GH16) family. Our study further elaborates the molecular basis for the lack of glucan recognition by Rv0315. Rv0315 has a large open groove, and this particular topology cannot bind oligosaccharide chains in solution, thus explaining the lack of detectable hydrolytic activity towards its substrate. Additionally, we identified Glu-176, a conserved catalytic residue in GH16 endo-beta-1,3-glucanases, as essential for Rv0315 to induce immunological responses. These results indicate that Rv0315 likely diverged from a broad-specificity ancestral GH16 glucanase, and this inactive member of the GH16 family offers new insights into the GH16 glucanase. Together, our findings suggest that an inactive beta-1,3-glucanase in Mtb drives T-helper 1 (Th1) immune responses, which may help develop more effective vaccines against Mtb infection.
Crystal structural basis for Rv0315, an immunostimulatory antigen and inactive beta-1,3-glucanase of Mycobacterium tuberculosis.,Dong W, Huang J, Li Y, Tan Y, Shen Z, Song Y, Wang D, Xiao S, Chen H, Fu ZF, Peng G Sci Rep. 2015 Oct 15;5:15073. doi: 10.1038/srep15073. PMID:26469317[1]
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
See Also
References
- ↑ Dong W, Huang J, Li Y, Tan Y, Shen Z, Song Y, Wang D, Xiao S, Chen H, Fu ZF, Peng G. Crystal structural basis for Rv0315, an immunostimulatory antigen and inactive beta-1,3-glucanase of Mycobacterium tuberculosis. Sci Rep. 2015 Oct 15;5:15073. doi: 10.1038/srep15073. PMID:26469317 doi:http://dx.doi.org/10.1038/srep15073
|